The Efficacy of Moclobemide in Treatment of Major Depression
The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of Depression (HRSD). As a result, a statistically...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Mesut Çetin
2021-03-01
|
| سلاسل: | Psychiatry and Clinical Psychopharmacology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/106 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|